Pharmacists in Magalia, CA Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Lisa Hohenthaner, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14137 Lakeridge Court, Magalia, CA 95954 Phone: 530-873-0460 |
 David Maurice Ruud, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14115 Lakeridge Cir, Magalia, CA 95954 Phone: 530-873-0800 Fax: 530-873-8033 |
Thanh Ba Duong, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14115 Lakeridge Cir, Magalia, CA 95954 Phone: 530-873-0800 |
Rodney C Clay, PHARM. DR. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14137 Lakeridge Cir, Magalia, CA 95954 Phone: 530-873-0460 Fax: 530-873-0703 |
Mr. Brian Kim Hunter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6068 Guilford Cir, Magalia, CA 95954 Phone: 530-533-3103 |
Steven Lane Green, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14115 Lakeridge Cir, Magalia, CA 95954 Phone: 530-873-0800 Fax: 530-873-8033 |
News Archive
Parasites that live inside cells use loophole to thwart immune system
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.
CRG researchers reprogramme lymphoma and leukaemia cells to halt malignancy
Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce likelihood of developing new tumours.
GlobalData: Lung cancer incidence rates are decreasing for men, but increasing among women
As World Lung Cancer Day approaches on August 1st, it serves as a reminder that lung cancer remains a major public health issue, particularly for women.
Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel
Luminex Corporation today announced it has received U.S. FDA clearance to add three new targets to its xTAG Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, Entamoeba histolytica and Vibrio cholerae.
› Verified 4 days ago